Skip to main content
SpringerLink
Log in
Book cover

Vitamin D in Chronic Kidney Disease pp 361–377Cite as

Vitamin D and Cardiovascular Calcification in Chronic Kidney Disease

  • Chapter
  • First Online:

  • 891 Accesses

Abstract

Cardiovascular calcification is a common problem among chronic kidney disease (CKD) patients. Altered vitamin D status (another key feature of CKD) has a major impact on mineral and bone disorders, including cardiovascular calcification. Preclinical and clinical studies have shown that both abnormally low and abnormally high vitamin D levels have local and systemic effects on cardiovascular calcification in CKD patients. This complex situation has major repercussions on the choice and monitoring of the dose of vitamin D prescribed to prevent and/or treat cardiovascular calcification in CKD.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   159.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Shanahan CM, Crouthamel MH, Kapustin A, Giachelli CM. Arterial calcification in chronic kidney disease: key roles for calcium and phosphate. Circ Res. 2011;109:697–711.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Pai A, Leaf EM, El-Abbadi M, Giachelli CM. Elastin degradation and vascular smooth muscle cell phenotype change precede cell loss and arterial medial calcification in a uremic mouse model of chronic kidney disease. Am J Pathol. 2011;178:764–73.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Bouvet C, Moreau S, Blanchette J, de Blois D, Moreau P. Sequential activation of matrix metalloproteinase 9 and transforming growth factor beta in arterial elastocalcinosis. Arterioscler Thromb Vasc Biol. 2008;28:856–62.

    Article  CAS  PubMed  Google Scholar 

  4. Perwad F, Zhang MYH, Tenenhouse HS, Portale AA. Fibroblast growth factor 23 impairs phosphorus and vitamin D metabolism in vivo and suppresses 25-hydroxyvitamin D-1alpha-hydroxylase expression in vitro. Am J Physiol Renal Physiol. 2007;293:F1577–83.

    Article  CAS  PubMed  Google Scholar 

  5. Hsu CH, Patel S. Uremic plasma contains factors inhibiting 1 alpha-hydroxylase activity. J Am Soc Nephrol. 1992;3:947–52.

    CAS  PubMed  Google Scholar 

  6. Michaud J, Naud J, Ouimet D, Demers C, Petit J-L, Leblond FA, Bonnardeaux A, Gascon-Barré M, Pichette V. Reduced hepatic synthesis of calcidiol in uremia. J Am Soc Nephrol. 2010;21:1488–97.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Glorieux G, Vanholder R. Blunted response to vitamin D in uremia. Kidney Int Suppl. 2001;78:S182–5.

    Article  CAS  PubMed  Google Scholar 

  8. Patel SR, Ke HQ, Vanholder R, Koenig RJ, Hsu CH. Inhibition of calcitriol receptor binding to vitamin D response elements by uremic toxins. J Clin Invest. 1995;96:50–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Shroff R, Egerton M, Bridel M, Shah V, Donald AE, Cole TJ, Hiorns MP, Deanfield JE, Rees L. A bimodal association of vitamin D levels and vascular disease in children on dialysis. J Am Soc Nephrol. 2008;19:1239–46.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Wu-Wong JR, Melnick J. Vascular calcification in chronic kidney failure: role of vitamin D receptor. Curr Opin Investig Drugs Lond Engl 2000. 2007;8:237–47.

    CAS  Google Scholar 

  11. Milliner DS, Zinsmeister AR, Lieberman E, Landing B. Soft tissue calcification in pediatric patients with end-stage renal disease. Kidney Int. 1990;38:931–6.

    Article  CAS  PubMed  Google Scholar 

  12. Goldsmith DJ, Covic A, Sambrook PA, Ackrill P. Vascular calcification in long-term haemodialysis patients in a single unit: a retrospective analysis. Nephron. 1997;77:37–43.

    Article  CAS  PubMed  Google Scholar 

  13. Briese S, Wiesner S, Will JC, Lembcke A, Opgen-Rhein B, Nissel R, Wernecke K-D, Andreae J, Haffner D, Querfeld U. Arterial and cardiac disease in young adults with childhood-onset end-stage renal disease-impact of calcium and vitamin D therapy. Nephrol Dial Transplant. 2006;21:1906–14.

    Article  CAS  PubMed  Google Scholar 

  14. Braun J, Oldendorf M, Moshage W, Heidler R, Zeitler E, Luft FC. Electron beam computed tomography in the evaluation of cardiac calcification in chronic dialysis patients. Am J Kidney Dis. 1996;27:394–401.

    Article  CAS  PubMed  Google Scholar 

  15. Goodman WG, Goldin J, Kuizon BD, et al. Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis. N Engl J Med. 2000;342:1478–83.

    Article  CAS  PubMed  Google Scholar 

  16. London GM, Guérin AP, Verbeke FH, Pannier B, Boutouyrie P, Marchais SJ, Mëtivier F. Mineral metabolism and arterial functions in end-stage renal disease: potential role of 25-hydroxyvitamin D deficiency. J Am Soc Nephrol. 2007;18:613–20.

    Article  CAS  PubMed  Google Scholar 

  17. Barreto DV, Barreto FC, Liabeuf S, Temmar M, Boitte F, Choukroun G, Fournier A, Massy ZA. Vitamin D affects survival independently of vascular calcification in chronic kidney disease. Clin J Am Soc Nephrol C. 2009;4:1128–35.

    Article  CAS  Google Scholar 

  18. Pillar R, G Lopes MG, Rocha LA, Cuppari L, Carvalho AB, Draibe SA, Canziani MEF. Severe hypovitaminosis D in chronic kidney disease: association with blood pressure and coronary artery calcification. Hypertens Res. 2013;36:428–32.

    Article  CAS  PubMed  Google Scholar 

  19. García-Canton C, Bosch E, Ramírez A, et al. Vascular calcification and 25-hydroxyvitamin D levels in non-dialysis patients with chronic kidney disease stages 4 and 5. Nephrol Dial Transplant. 2011;26:2250–6.

    Article  PubMed  CAS  Google Scholar 

  20. Lee S-Y, Kim H-Y, Gu SW, Kim H-J, Yang DH. 25-hydroxyvitamin D levels and vascular calcification in predialysis and dialysis patients with chronic kidney disease. Kidney Blood Press Res. 2012;35:349–54.

    Article  CAS  PubMed  Google Scholar 

  21. Matias PJ, Ferreira C, Jorge C, Borges M, Aires I, Amaral T, Gil C, Cortez J, Ferreira A. 25-Hydroxyvitamin D3, arterial calcifications and cardiovascular risk markers in haemodialysis patients. Nephrol Dial Transplant. 2009;24:611–8.

    Article  CAS  PubMed  Google Scholar 

  22. de Boer IH, Kestenbaum B, Shoben AB, Michos ED, Sarnak MJ, Siscovick DS. 25-hydroxyvitamin D levels inversely associate with risk for developing coronary artery calcification. J Am Soc Nephrol. 2009;20:1805–12.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  23. Watson KE, Abrolat ML, Malone LL, Hoeg JM, Doherty T, Detrano R, Demer LL. Active serum vitamin D levels are inversely correlated with coronary calcification. Circulation. 1997;96:1755–60.

    Article  CAS  PubMed  Google Scholar 

  24. Ogawa T, Ishida H, Akamatsu M, Matsuda N, Fujiu A, Ito K, Ando Y, Nitta K. Relation of oral 1alpha-hydroxy vitamin D3 to the progression of aortic arch calcification in hemodialysis patients. Heart Vessels. 2010;25:1–6.

    Article  PubMed  Google Scholar 

  25. Zheng Z, Shi H, Jia J, Li D, Lin S. Vitamin D supplementation and mortality risk in chronic kidney disease: a meta-analysis of 20 observational studies. BMC Nephrol. 2013;14:199.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  26. Wang L, Manson JE, Song Y, Sesso HD. Systematic review: vitamin D and calcium supplementation in prevention of cardiovascular events. Ann Intern Med. 2010;152:315–23.

    Article  PubMed  Google Scholar 

  27. Kandula P, Dobre M, Schold JD, Schreiber MJ, Mehrotra R, Navaneethan SD. Vitamin D supplementation in chronic kidney disease: a systematic review and meta-analysis of observational studies and randomized controlled trials. Clin J Am Soc Nephrol C. 2011;6:50–62.

    Article  CAS  Google Scholar 

  28. Mann MC, Hobbs AJ, Hemmelgarn BR, Roberts DJ, Ahmed SB, Rabi DM. Effect of oral vitamin D analogs on mortality and cardiovascular outcomes among adults with chronic kidney disease: a meta-analysis. Clin Kidney J. 2015;8:41–8.

    Article  PubMed  Google Scholar 

  29. Delanaye P, Weekers L, Warling X, Moonen M, Smelten N, Médart L, Krzesinski J-M, Cavalier E. Cholecalciferol in haemodialysis patients: a randomized, double-blind, proof-of-concept and safety study. Nephrol Dial Transplant. 2013;28:1779–86.

    Article  PubMed  Google Scholar 

  30. Massart A, Debelle FD, Racapé J, Gervy C, Husson C, Dhaene M, Wissing KM, Nortier JL. Biochemical parameters after cholecalciferol repletion in hemodialysis: results From the VitaDial randomized trial. Am J Kidney Dis. 2014;64:696–705.

    Article  CAS  PubMed  Google Scholar 

  31. Melamed ML, Michos ED, Post W, Astor B. 25-hydroxyvitamin D levels and the risk of mortality in the general population. Arch Intern Med. 2008;168:1629–37.

    Article  PubMed  PubMed Central  Google Scholar 

  32. Eisenstein R, Zeruolis L. Vitamin D-induced aortic calcification. Arch Pathol. 1964;77:27–35.

    CAS  PubMed  Google Scholar 

  33. Takeo S, Anan M, Fujioka K, Kajihara T, Hiraga S, Miyake K, Tanonaka K, Minematsu R, Mori H, Taniguchi Y. Functional changes of aorta with massive accumulation of calcium. Atherosclerosis. 1989;77:175–81.

    Article  CAS  PubMed  Google Scholar 

  34. Hass GM, Landerholm W, Hemmens A. Production of calcific athero-arteriosclerosis and thromboarteritis with nicotine, vitamin D and dietary cholesterol. Am J Pathol. 1966;49:739–71.

    CAS  PubMed  PubMed Central  Google Scholar 

  35. Synetos A, Toutouzas K, Benetos G, et al. Catheter based inhibition of arterial calcification by bisphosphonates in an experimental atherosclerotic rabbit animal model. Int J Cardiol. 2014;176:177–81.

    Article  PubMed  Google Scholar 

  36. Ngo DTM, Stafford I, Kelly DJ, et al. Vitamin D(2) supplementation induces the development of aortic stenosis in rabbits: interactions with endothelial function and thioredoxin-interacting protein. Eur J Pharmacol. 2008;590:290–6.

    Article  CAS  PubMed  Google Scholar 

  37. Liu LB, Taylor CB, Peng SK, Mikkelson B. Experimental arteriosclerosis in Rhesus monkeys induced by multiple risk factors: cholesterol, vitamin D, and nictotine. Paroi Arterielle. 1979;5:25–37.

    CAS  PubMed  Google Scholar 

  38. Bas A, Lopez I, Perez J, Rodriguez M, Aguilera-Tejero E. Reversibility of calcitriol-induced medial artery calcification in rats with intact renal function. J Bone Miner Res. 2006;21:484–90.

    Article  CAS  PubMed  Google Scholar 

  39. Haffner D, Hocher B, Müller D, et al. Systemic cardiovascular disease in uremic rats induced by 1,25(OH)2D3. J Hypertens. 2005;23:1067–75.

    Article  CAS  PubMed  Google Scholar 

  40. Henley C, Colloton M, Cattley RC, Shatzen E, Towler DA, Lacey D, Martin D. 1,25-Dihydroxyvitamin D3 but not cinacalcet HCl (Sensipar/Mimpara) treatment mediates aortic calcification in a rat model of secondary hyperparathyroidism. Nephrol Dial Transplant. 2005;20:1370–7.

    Article  CAS  PubMed  Google Scholar 

  41. Cardús A, Panizo S, Parisi E, Fernandez E, Valdivielso JM. Differential effects of vitamin D analogs on vascular calcification. J Bone Miner Res. 2007;22:860–6.

    Article  PubMed  Google Scholar 

  42. Lopez I, Mendoza FJ, Aguilera-Tejero E, Perez J, Guerrero F, Martin D, Rodriguez M. The effect of calcitriol, paricalcitol, and a calcimimetic on extraosseous calcifications in uremic rats. Kidney Int. 2008;73:300–7.

    Article  CAS  PubMed  Google Scholar 

  43. Koleganova N, Piecha G, Ritz E, Schmitt CP, Gross M-L. A calcimimetic (R-568), but not calcitriol, prevents vascular remodeling in uremia. Kidney Int. 2009;75:60–71.

    Article  CAS  PubMed  Google Scholar 

  44. Ivanovski O, Nikolov IG, Joki N, et al. The calcimimetic R-568 retards uremia-enhanced vascular calcification and atherosclerosis in apolipoprotein E deficient (apoE−/−) mice. Atherosclerosis. 2009;205:55–62.

    Article  CAS  PubMed  Google Scholar 

  45. Becker LE, Koleganova N, Piecha G, Noronha IL, Zeier M, Geldyyev A, Kökeny G, Ritz E, Gross M-L. Effect of paricalcitol and calcitriol on aortic wall remodeling in uninephrectomized ApoE knockout mice. Am J Physiol Renal Physiol. 2011;300:F772–82.

    Article  CAS  PubMed  Google Scholar 

  46. Mathew S, Lund RJ, Chaudhary LR, Geurs T, Hruska KA. Vitamin D receptor activators can protect against vascular calcification. J Am Soc Nephrol. 2008;19:1509–19.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  47. Lau WL, Leaf EM, Hu MC, Takeno MM, Kuro-o M, Moe OW, Giachelli CM. Vitamin D receptor agonists increase klotho and osteopontin while decreasing aortic calcification in mice with chronic kidney disease fed a high phosphate diet. Kidney Int. 2012;82:1261–70.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  48. Schmidt N, Brandsch C, Kühne H, Thiele A, Hirche F, Stangl GI. Vitamin D receptor deficiency and low vitamin D diet stimulate aortic calcification and osteogenic key factor expression in mice. PLoS One. 2012;7:e35316.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  49. Schmidt N, Brandsch C, Schutkowski A, Hirche F, Stangl GI. Dietary vitamin D inadequacy accelerates calcification and osteoblast-like cell formation in the vascular system of LDL receptor knockout and wild-type mice. J Nutr. 2014;144:638–46.

    Article  CAS  PubMed  Google Scholar 

  50. Ellam T, Hameed A, ul Haque R, Muthana M, Wilkie M, Francis SE, Chico TJA. Vitamin D deficiency and exogenous vitamin D excess similarly increase diffuse atherosclerotic calcification in apolipoprotein E knockout mice. PLoS One. 2014;9:e88767.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  51. Jono S, Nishizawa Y, Shioi A, Morii H. 1,25-Dihydroxyvitamin D3 increases in vitro vascular calcification by modulating secretion of endogenous parathyroid hormone-related peptide. Circulation. 1998;98:1302–6.

    Article  CAS  PubMed  Google Scholar 

  52. Zebger-Gong H, Müller D, Diercke M, Haffner D, Hocher B, Verberckmoes S, Schmidt S, D’Haese PC, Querfeld U. 1,25-Dihydroxyvitamin D3-induced aortic calcifications in experimental uremia: up-regulation of osteoblast markers, calcium-transporting proteins and osterix. J Hypertens. 2011;29:339–48.

    Article  CAS  PubMed  Google Scholar 

  53. Martínez-Moreno JM, Muñoz-Castañeda JR, Herencia C, et al. In vascular smooth muscle cells paricalcitol prevents phosphate-induced Wnt/β-catenin activation. Am J Physiol Renal Physiol. 2012;303:F1136–44.

    Article  PubMed  CAS  Google Scholar 

  54. Han M-S, Che X, Cho G, et al. Functional cooperation between vitamin D receptor and Runx2 in vitamin D-induced vascular calcification. PLoS One. 2013;8:e83584.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  55. Panizo S, Cardus A, Encinas M, Parisi E, Valcheva P, López-Ongil S, Coll B, Fernandez E, Valdivielso JM. RANKL increases vascular smooth muscle cell calcification through a RANK-BMP4-dependent pathway. Circ Res. 2009;104:1041–8.

    Article  CAS  PubMed  Google Scholar 

  56. Wu-Wong JR, Noonan W, Ma J, Dixon D, Nakane M, Bolin AL, Koch KA, Postl S, Morgan SJ, Reinhart GA. Role of phosphorus and vitamin D analogs in the pathogenesis of vascular calcification. J Pharmacol Exp Ther. 2006;318:90–8.

    Article  CAS  PubMed  Google Scholar 

  57. Block GA, Martin KJ, de Francisco ALM, et al. Cinacalcet for secondary hyperparathyroidism in patients receiving hemodialysis. N Engl J Med. 2004;350:1516–25.

    Article  CAS  PubMed  Google Scholar 

  58. Kawata T, Nagano N, Obi M, Miyata S, Koyama C, Kobayashi N, Wakita S, Wada M. Cinacalcet suppresses calcification of the aorta and heart in uremic rats. Kidney Int. 2008;74:1270–7.

    Article  CAS  PubMed  Google Scholar 

  59. Raggi P, Chertow GM, Torres PU, et al. The ADVANCE study: a randomized study to evaluate the effects of cinacalcet plus low-dose vitamin D on vascular calcification in patients on hemodialysis. Nephrol Dial Transplant. 2011;26:1327–39.

    Article  CAS  PubMed  Google Scholar 

  60. Molostvov G, James S, Fletcher S, Bennett J, Lehnert H, Bland R, Zehnder D. Extracellular calcium-sensing receptor is functionally expressed in human artery. Am J Physiol Renal Physiol. 2007;293:F946–55.

    Article  CAS  PubMed  Google Scholar 

  61. Alam M, Kirton JP, Wilkinson FL, et al. Calcification is associated with loss of functional calcium-sensing receptor in vascular smooth muscle cells. Cardiovasc Res. 2009;81:260–8.

    Article  CAS  PubMed  Google Scholar 

  62. Mendoza FJ, Martinez-Moreno J, Almaden Y, Rodriguez-Ortiz ME, Lopez I, Estepa JC, Henley C, Rodriguez M, Aguilera-Tejero E. Effect of calcium and the calcimimetic AMG 641 on matrix-Gla protein in vascular smooth muscle cells. Calcif Tissue Int. 2011;88:169–78.

    Article  CAS  PubMed  Google Scholar 

  63. Hénaut L, Boudot C, Massy ZA, Lopez-Fernandez I, Dupont S, Mary A, Drüeke TB, Kamel S, Brazier M, Mentaverri R. Calcimimetics increase CaSR expression and reduce mineralization in vascular smooth muscle cells: mechanisms of action. Cardiovasc Res. 2014;101:256–65.

    Article  PubMed  CAS  Google Scholar 

  64. Canaff L, Hendy GN. Human calcium-sensing receptor gene. Vitamin D response elements in promoters P1 and P2 confer transcriptional responsiveness to 1,25-dihydroxyvitamin D. J Biol Chem. 2002;277:30337–50.

    Article  CAS  PubMed  Google Scholar 

  65. Mary A, Hénaut L, Boudot C, Six I, Brazier M, Massy ZA, Drüeke TB, Kamel S, Mentaverri R. Calcitriol prevents in vitro vascular smooth muscle cell mineralization by regulating calcium-sensing receptor expression. Endocrinology. 2015;156:1965–74.

    Article  CAS  PubMed  Google Scholar 

  66. Kaysen GA. The microinflammatory state in uremia: causes and potential consequences. J Am Soc Nephrol. 2001;12:1549–57.

    CAS  PubMed  Google Scholar 

  67. Moe SM, Chen NX. Inflammation and vascular calcification. Blood Purif. 2005;23:64–71.

    Article  PubMed  Google Scholar 

  68. Zimmermann J, Herrlinger S, Pruy A, Metzger T, Wanner C. Inflammation enhances cardiovascular risk and mortality in hemodialysis patients. Kidney Int. 1999;55:648–58.

    Article  CAS  PubMed  Google Scholar 

  69. Saulnier P-J, Gand E, Ragot S, et al. Association of serum concentration of TNFR1 with all-cause mortality in patients with type 2 diabetes and chronic kidney disease: follow-up of the SURDIAGENE Cohort. Diabetes Care. 2014;37:1425–31.

    Article  CAS  PubMed  Google Scholar 

  70. Tintut Y, Patel J, Parhami F, Demer LL. Tumor necrosis factor-alpha promotes in vitro calcification of vascular cells via the cAMP pathway. Circulation. 2000;102:2636–42.

    Article  CAS  PubMed  Google Scholar 

  71. Lee H-L, Woo KM, Ryoo H-M, Baek J-H. Tumor necrosis factor-alpha increases alkaline phosphatase expression in vascular smooth muscle cells via MSX2 induction. Biochem Biophys Res Commun. 2010;391:1087–92.

    Article  CAS  PubMed  Google Scholar 

  72. Son B-K, Akishita M, Iijima K, Kozaki K, Maemura K, Eto M, Ouchi Y. Adiponectin antagonizes stimulatory effect of tumor necrosis factor-alpha on vascular smooth muscle cell calcification: regulation of growth arrest-specific gene 6-mediated survival pathway by adenosine 5′-monophosphate-activated protein kinase. Endocrinology. 2008;149:1646–53.

    Article  CAS  PubMed  Google Scholar 

  73. Masuda M, Miyazaki-Anzai S, Levi M, Ting TC, Miyazaki M. PERK-eIF2α-ATF4-CHOP signaling contributes to TNFα-induced vascular calcification. J Am Heart Assoc. 2013;2:e000238.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  74. Zhao G, Xu M-J, Zhao M-M, Dai X-Y, Kong W, Wilson GM, Guan Y, Wang C-Y, Wang X. Activation of nuclear factor-kappa B accelerates vascular calcification by inhibiting ankylosis protein homolog expression. Kidney Int. 2012;82:34–44.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  75. Kaden JJ, Kiliç R, Sarikoç A, Hagl S, Lang S, Hoffmann U, Brueckmann M, Borggrefe M. Tumor necrosis factor alpha promotes an osteoblast-like phenotype in human aortic valve myofibroblasts: a potential regulatory mechanism of valvular calcification. Int J Mol Med. 2005;16:869–72.

    CAS  PubMed  Google Scholar 

  76. Aoshima Y, Mizobuchi M, Ogata H, Kumata C, Nakazawa A, Kondo F, Ono N, Koiwa F, Kinugasa E, Akizawa T. Vitamin D receptor activators inhibit vascular smooth muscle cell mineralization induced by phosphate and TNF-α. Nephrol Dial Transplant. 2012;27:1800–6.

    Article  CAS  PubMed  Google Scholar 

  77. Guerrero F, Montes de Oca A, Aguilera-Tejero E, Zafra R, Rodríguez M, López I. The effect of vitamin D derivatives on vascular calcification associated with inflammation. Nephrol Dial Transplant. 2012;27:2206–12.

    Article  CAS  PubMed  Google Scholar 

  78. Wang Y, DeLuca HF. Is the vitamin d receptor found in muscle? Endocrinology. 2011;152:354–63.

    Article  CAS  PubMed  Google Scholar 

  79. Christakos S, Lieben L, Masuyama R, Carmeliet G. Vitamin D endocrine system and the intestine. BoneKEy Rep. 2014;3:496.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  80. Mizobuchi M, Finch JL, Martin DR, Slatopolsky E. Differential effects of vitamin D receptor activators on vascular calcification in uremic rats. Kidney Int. 2007;72:709–15.

    Article  CAS  PubMed  Google Scholar 

  81. Coen G, Ballanti P, Mantella D, et al. Bone turnover, osteopenia and vascular calcifications in hemodialysis patients. A histomorphometric and multislice CT study. Am J Nephrol. 2009;29:145–52.

    Article  CAS  PubMed  Google Scholar 

  82. Stenvinkel P, Ketteler M, Johnson RJ, Lindholm B, Pecoits-Filho R, Riella M, Heimbürger O, Cederholm T, Girndt M. IL-10, IL-6, and TNF-alpha: central factors in the altered cytokine network of uremia – the good, the bad, and the ugly. Kidney Int. 2005;67:1216–33.

    Article  CAS  PubMed  Google Scholar 

  83. Jean G, Bresson E, Terrat J-C, Vanel T, Hurot J-M, Lorriaux C, Mayor B, Chazot C. Peripheral vascular calcification in long-haemodialysis patients: associated factors and survival consequences. Nephrol Dial Transplant. 2009;24:948–55.

    Article  CAS  PubMed  Google Scholar 

  84. Rysz J, Banach M, Cialkowska-Rysz A, Stolarek R, Barylski M, Drozdz J, Okonski P. Blood serum levels of IL-2, IL-6, IL-8, TNF-alpha and IL-1beta in patients on maintenance hemodialysis. Cell Mol Immunol. 2006;3:151–4.

    CAS  PubMed  Google Scholar 

  85. Lee C-T, Chua S, Hsu C-Y, Tsai Y-C, Ng H-Y, Kuo C-C, Wu C-H, Chen T-C, Chiu TT-Y, Lee Y-T. Biomarkers associated with vascular and valvular calcification in chronic hemodialysis patients. Dis Markers. 2013;34:229–35.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  86. Pecoits-Filho R, Bárány P, Lindholm B, Heimbürger O, Stenvinkel P. Interleukin-6 is an independent predictor of mortality in patients starting dialysis treatment. Nephrol Dial Transplant. 2002;17:1684–8.

    Article  CAS  PubMed  Google Scholar 

  87. Zhang Y, Leung DYM, Richers BN, Liu Y, Remigio LK, Riches DW, Goleva E. Vitamin D inhibits monocyte/macrophage proinflammatory cytokine production by targeting MAPK phosphatase-1. J Immunol Baltim Md 1950. 2012;188:2127–35.

    CAS  Google Scholar 

  88. Panichi V, De Pietro S, Andreini B, Bianchi AM, Migliori M, Taccola D, Giovannini L, Tetta C, Palla R. Calcitriol modulates in vivo and in vitro cytokine production: a role for intracellular calcium. Kidney Int. 1998;54:1463–9.

    Article  CAS  PubMed  Google Scholar 

  89. Matias PJ, Jorge C, Ferreira C, Borges M, Aires I, Amaral T, Gil C, Cortez J, Ferreira A. Cholecalciferol supplementation in hemodialysis patients: effects on mineral metabolism, inflammation, and cardiac dimension parameters. Clin J Am Soc Nephrol C. 2010;5:905–11.

    Article  CAS  Google Scholar 

  90. Stubbs JR, Idiculla A, Slusser J, Menard R, Quarles LD. Cholecalciferol supplementation alters calcitriol-responsive monocyte proteins and decreases inflammatory cytokines in ESRD. J Am Soc Nephrol. 2010;21:353–61.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  91. Verouti SN, Tsoupras AB, Alevizopoulou F, Demopoulos CA, Iatrou C. Paricalcitol effects on activities and metabolism of platelet activating factor and on inflammatory cytokines in hemodialysis patients. Int J Artif Organs. 2013;36:87–96.

    Article  PubMed  CAS  Google Scholar 

  92. Li X, Speer MY, Yang H, Bergen J, Giachelli CM. Vitamin D receptor activators induce an anticalcific paracrine program in macrophages: requirement of osteopontin. Arterioscler Thromb Vasc Biol. 2010;30:321–6.

    Article  CAS  PubMed  Google Scholar 

  93. Kaden JJ, Dempfle C-E, Grobholz R, et al. Interleukin-1 beta promotes matrix metalloproteinase expression and cell proliferation in calcific aortic valve stenosis. Atherosclerosis. 2003;170:205–11.

    Article  CAS  PubMed  Google Scholar 

  94. Isoda K, Matsuki T, Kondo H, Iwakura Y, Ohsuzu F. Deficiency of interleukin-1 receptor antagonist induces aortic valve disease in BALB/c mice. Arterioscler Thromb Vasc Biol. 2010;30:708–15.

    Article  CAS  PubMed  Google Scholar 

  95. Callegari A, Coons ML, Ricks JL, Rosenfeld ME, Scatena M. Increased calcification in osteoprotegerin deficient smooth muscle cells: dependence on receptor activator of NF-kB ligand and interleukin-6. J Vasc Res. 2014;51:118–31.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  96. El Husseini D, Boulanger M-C, Mahmut A, Bouchareb R, Laflamme M-H, Fournier D, Pibarot P, Bossé Y, Mathieu P. P2Y2 receptor represses IL-6 expression by valve interstitial cells through Akt: implication for calcific aortic valve disease. J Mol Cell Cardiol. 2014;72:146–56.

    Article  PubMed  CAS  Google Scholar 

  97. Shimada T, Kakitani M, Yamazaki Y, Hasegawa H, Takeuchi Y, Fujita T, Fukumoto S, Tomizuka K, Yamashita T. Targeted ablation of Fgf23 demonstrates an essential physiological role of FGF23 in phosphate and vitamin D metabolism. J Clin Invest. 2004;113:561–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  98. Kuro-o M, Matsumura Y, Aizawa H, et al. Mutation of the mouse klotho gene leads to a syndrome resembling ageing. Nature. 1997;390:45–51.

    Article  CAS  PubMed  Google Scholar 

  99. Lim K, Lu T-S, Molostvov G, Lee C, Lam FT, Zehnder D, Hsiao L-L. Vascular Klotho deficiency potentiates the development of human artery calcification and mediates resistance to fibroblast growth factor 23. Circulation. 2012;125:2243–55.

    Article  CAS  PubMed  Google Scholar 

  100. Jimbo R, Kawakami-Mori F, Mu S, Hirohama D, Majtan B, Shimizu Y, Yatomi Y, Fukumoto S, Fujita T, Shimosawa T. Fibroblast growth factor 23 accelerates phosphate-induced vascular calcification in the absence of Klotho deficiency. Kidney Int. 2014;85:1103–11.

    Article  CAS  PubMed  Google Scholar 

  101. Hu MC, Shi M, Zhang J, Quiñones H, Griffith C, Kuro-o M, Moe OW. Klotho deficiency causes vascular calcification in chronic kidney disease. J Am Soc Nephrol. 2011;22:124–36.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  102. Haussler MR, Whitfield GK, Kaneko I, Forster R, Saini R, Hsieh J-C, Haussler CA, Jurutka PW. The role of vitamin D in the FGF23, klotho, and phosphate bone-kidney endocrine axis. Rev Endocr Metab Disord. 2012;13:57–69.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  103. Lomashvili KA, Wang X, O’Neill WC. Role of local versus systemic vitamin D receptors in vascular calcification. Arterioscler Thromb Vasc Biol. 2014;34:146–51.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. INSERM Unit 1088 and Department of Biochemistry, University Hospital, University of Picardie Jules Vernes and CHU d’amiens, Picardie, France

    Lucie Hénaut PhD

  2. INSERM Unit 1088, University of Picardie Jules Vernes, Amiens, France

    Aurélien Mary PharmD, PhD

  3. INSERM Unit 1088 and Department of Biochemistry, University Hospital, University of Picardie Jules Vernes and CHU d’amiens, Centre Universitaire de Recherche en Santé (CURS), Chemin du Thil, Amiens, Picardie, France

    Said Kamel PharmD, PhD

  4. Division of Nephrology, Ambroise Paré University Hospital, Boulogne, France

    Ziad A. Massy MD, PhD, FERA

Authors
  1. Lucie Hénaut PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Aurélien Mary PharmD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Said Kamel PharmD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Ziad A. Massy MD, PhD, FERA
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ziad A. Massy MD, PhD, FERA .

Editor information

Editors and Affiliations

  1. Ramsay-Générale de Santé, Clinique du Landy, Saint Ouen, France

    Pablo A. Ureña Torres

  2. San Paolo Hospital, DiSS University of Milan, Milan, Italy

    Mario Cozzolino

  3. VU University Medical Center, Amsterdam, The Netherlands

    Marc G. Vervloet

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Hénaut, L., Mary, A., Kamel, S., Massy, Z.A. (2016). Vitamin D and Cardiovascular Calcification in Chronic Kidney Disease. In: Ureña Torres, P., Cozzolino, M., Vervloet, M. (eds) Vitamin D in Chronic Kidney Disease. Springer, Cham. https://doi.org/10.1007/978-3-319-32507-1_21

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-32507-1_21

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-32505-7

  • Online ISBN: 978-3-319-32507-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation